An Update in Drug-Induced Thrombotic Microangiopathy

被引:29
作者
Chatzikonstantinou, Thomas [1 ]
Gavriilaki, Maria [2 ]
Anagnostopoulos, Achilles [1 ]
Gavriilaki, Eleni [1 ]
机构
[1] G Papanicolaou Hosp, Hematol Dept, BMT Unit, Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, AHEPA Hosp, Lab Clin Neurophysiol, Thessaloniki, Greece
关键词
thrombotic microangiopathy; drug; hematology; oncology; neurology; HEMOLYTIC-UREMIC SYNDROME; THROMBOCYTOPENIC PURPURA; MULTIPLE-SCLEROSIS; RENAL-FAILURE; MITOMYCIN-C; GEMCITABINE; THERAPY; ECULIZUMAB; PATIENT; TRANSPLANTATION;
D O I
10.3389/fmed.2020.00212
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:7
相关论文
共 89 条
  • [1] Drug-induced thrombotic microangiopathy: a systematic review of published reports
    Al-Nouri, Zayd L.
    Reese, Jessica A.
    Terrell, Deirdra R.
    Vesely, Sara K.
    George, James N.
    [J]. BLOOD, 2015, 125 (04) : 616 - 618
  • [2] Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab
    Allinovi, Marco
    Cirami, Calogero Lino
    Caroti, Leonardo
    Antognoli, Giulia
    Farsetti, Silvia
    Amato, Maria Pia
    Minetti, Enrico Eugenio
    [J]. CLINICAL KIDNEY JOURNAL, 2017, 10 (05) : 625 - 631
  • [3] Drug-Induced Thrombotic Microangiopathy due to Cumulative Toxicity of Ixazomib
    Atallah-Yunes, Suheil Albert
    Soe, Myat Han
    [J]. CASE REPORTS IN HEMATOLOGY, 2018, 2018
  • [4] Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
    Baysal, Mehmet
    Umit, Elif Gulsum
    Saritas, Fatih
    Kodal, Nil Su
    Demir, Ahmet Muzaffer
    [J]. BALKAN MEDICAL JOURNAL, 2018, 35 (05) : 398 - 399
  • [5] CARCINOMA-ASSOCIATED HEMOLYTIC-UREMIC SYNDROME - A COMPLICATION OF MITOMYCIN-C CHEMOTHERAPY
    CANTRELL, JE
    PHILLIPS, TM
    SCHEIN, PS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (05) : 723 - 734
  • [6] Renal and pulmonary thrombotic microangiopathy triggered by proteasome-inhibitor therapy in patient with smoldering myeloma
    Cassol, Clarissa A.
    Williams, Michael P. A.
    Caza, Tiffany N.
    Rodriguez, Sophia
    [J]. MEDICINE, 2019, 98 (39)
  • [7] Eculizumab in secondary atypical haemolytic uraemic syndrome
    Cavero, Teresa
    Rabasco, Cristina
    Lopez, Antia
    Roman, Elena
    Avila, Ana
    Sevillano, Angel
    Huerta, Ana
    Rojas-Rivera, Jorge
    Fuentes, Carolina
    Blasco, Miquel
    Jarque, Ana
    Garcia, Alba
    Mendizabal, Santiago
    Gavela, Eva
    Macia, Manuel
    Quintana, Luis F.
    Maria Romera, Ana
    Borrego, Josefa
    Arjona, Emi
    Espinosa, Mario
    Portoles, Jose
    Gracia-Iguacel, Carolina
    Gonzalez-Parra, Emilio
    Aljama, Pedro
    Morales, Enrique
    Cao, Mercedes
    Rodriguez de Cordoba, Santiago
    Praga, Manuel
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (03) : 466 - 474
  • [8] Development of Thrombotic Thrombocytopenic Purpura in Association With the Monoclonal Antibody, Golimumab, Used to Treat Rheumatoid Arthritis, in a Case With Literature Review
    Cepeda, Jillian
    Liedke, Christopher
    Patnaik, Asha
    Yao, Qingping
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 (04) : 229 - 231
  • [9] Recurrent Atypical Hemolytic Uremic Syndrome in Children With Acute Lymphoblastic Leukemia Undergoing Maintenance Chemotherapy
    Cheng, Geoffrey
    Ozgonenel, Bulent
    Bhambhani, Kanta
    Kapur, Gaurav
    Smith, Richard J.
    Savasan, Sureyya
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (07) : 560 - 562
  • [10] Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
    Coles, Alasdair J.
    Twyman, Cary L.
    Arnold, Douglas L.
    Cohen, Jeffrey A.
    Confavreux, Christian
    Fox, Edward J.
    Hartung, Hans-Peter
    Havrdova, Eva
    Selmaj, Krzysztof W.
    Weiner, Howard L.
    Miller, Tamara
    Fisher, Elizabeth
    Sandbrink, Rupert
    Lake, Stephen L.
    Margolin, David H.
    Oyuela, Pedro
    Panzara, Michael A.
    Compston, D. Alastair S.
    [J]. LANCET, 2012, 380 (9856) : 1829 - 1839